Biotech Values

[guerlain]

Why would MRK buy a drug that's still on participial clinical hold?
Without that hold lift, the whole program is basically worthless as they can't run any trials longer than 6 months.

ESPR said the two-year carcinogenicity studies were already completed in 2Q14 and they plan to submit to FDA in early 2015.
So basically they know all the animal study data, but they won't disclose it until they submit and hear back from FDA...
Frankly it smells like the data are not 100% clean and they probably need some fighting with the FDA...